Histone Therapeutics, Canada
Dr. Block is CEO and co-founder of Histone Therapeutics, a company focused on epigenome editing using computer-designed proteins. His previous roles include Senior Vice President of Corporate Development at Notch Therapeutics, Director of Business Development at Astellas Pharma, and VP of Business Development at Universal Cells. Dr. Block holds a Ph.D. in Molecular Biology, trained under Dr. Darwin Prockop, and completed a fellowship at the University of Washington Institute for Stem Cell and Regenerative Medicine.
FRONTIERS IN EPIGENETIC CONTROL FOR ENHANCED STEM CELL THERAPIES
Wednesday, July 10, 2024
4:00 PM – 5:30 PM CEST